Quillivant ER (methylphenidate HCl extended-release) chewable tablets are now available for treatment of attention deficit hyperactivity disorder in children ages six to 12.
Close to 60% of patients in U.S. national ambulatory survey were prescribed two or more psychotropic medications in 2005, a sharp rise from the 42.6% seen in 1996.
More than two-thirds of U.S. children and teens who saw a doctor for pink eye left with a prescription for antibiotic eye drops, new research has found.